Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Building and Rebuilding: The National Public Health Laboratory Systems and Services Before and After the Earthquake and Cholera Epidemic, Haiti, 2009-2015.

Jean Louis F, Buteau J, Boncy J, Anselme R, Stanislas M, Nagel MC, Juin S, Charles M, Burris R, Antoine E, Yang C, Kalou M, Vertefeuille J, Marston BJ, Lowrance DW, Deyde V.

Am J Trop Med Hyg. 2017 Oct;97(4_Suppl):21-27. doi: 10.4269/ajtmh.16-0941.

2.

Acquisition of Expert/Non-Expert Vocabulary from Reformulations.

Antoine E, Grabar N.

Stud Health Technol Inform. 2017;235:521-525.

PMID:
28423847
3.

A new cis-acting motif is required for the axonal SMN-dependent Anxa2 mRNA localization.

Rihan K, Antoine E, Maurin T, Bardoni B, Bordonné R, Soret J, Rage F.

RNA. 2017 Jun;23(6):899-909. doi: 10.1261/rna.056788.116. Epub 2017 Mar 3.

4.

The stentable in vitro artery: an instrumented platform for endovascular device development and optimization.

Antoine EE, Cornat FP, Barakat AI.

J R Soc Interface. 2016 Dec;13(125). pii: 20160834. doi: 10.1098/rsif.2016.0834.

5.

A simple microfluidic device to study cell-scale endothelial mechanotransduction.

Lafaurie-Janvore J, Antoine EE, Perkins SJ, Babataheri A, Barakat AI.

Biomed Microdevices. 2016 Aug;18(4):63. doi: 10.1007/s10544-016-0090-y.

PMID:
27402497
6.

Maintaining professional activity during breast cancer treatment.

Ganem G, Antoine EC, Touboul C, Naman H, Dohollou N, Facchini T, Coscas Y, Lortholary A, Catala S, Jacquot S, Lhomel C, Eisinger F.

Eur J Cancer Care (Engl). 2016 May;25(3):458-65. doi: 10.1111/ecc.12460. Epub 2016 Feb 18.

PMID:
26891443
7.

[Granulocyte- colony stimulating factor (G-CSF) use in clinical practice in patients receiving chemotherapy for breast cancer: The Opaline Study].

Jacot W, Antoine EC, Hacini M, Giron C, Rivière A, Moureau-Zabotto L, Cassin D, Yazbek G, Orfeuvre H, Sakek N, Diab R, Bastit L, Mille D, Azria D.

Bull Cancer. 2015 Dec;102(12):979-92. doi: 10.1016/j.bulcan.2015.09.004. Epub 2015 Nov 17. French.

PMID:
26597475
8.

Impact Of Her2 Testing Quality Improvement From A Health Economic Perspective.

Tilleul P, Bellocq J, Tehard B, Penault-Llorca F, Salomon A, Antoine E.

Value Health. 2015 Nov;18(7):A373. doi: 10.1016/j.jval.2015.09.766. Epub 2015 Oct 20. No abstract available.

9.

Tunable collagen I hydrogels for engineered physiological tissue micro-environments.

Antoine EE, Vlachos PP, Rylander MN.

PLoS One. 2015 Mar 30;10(3):e0122500. doi: 10.1371/journal.pone.0122500. eCollection 2015.

10.

Review of collagen I hydrogels for bioengineered tissue microenvironments: characterization of mechanics, structure, and transport.

Antoine EE, Vlachos PP, Rylander MN.

Tissue Eng Part B Rev. 2014 Dec;20(6):683-96. doi: 10.1089/ten.TEB.2014.0086. Epub 2014 Jul 22. Review.

11.

Characterization and in vivo functional analysis of the Schizosaccharomyces pombe ICLN gene.

Barbarossa A, Antoine E, Neel H, Gostan T, Soret J, Bordonné R.

Mol Cell Biol. 2014 Feb;34(4):595-605. doi: 10.1128/MCB.01407-13. Epub 2013 Dec 2.

12.

Flow measurements in a blood-perfused collagen vessel using x-ray micro-particle image velocimetry.

Antoine E, Buchanan C, Fezzaa K, Lee WK, Rylander MN, Vlachos P.

PLoS One. 2013 Nov 18;8(11):e81198. doi: 10.1371/journal.pone.0081198. eCollection 2013.

13.

Lymphotoxin signaling is initiated by the viral polymerase in HCV-linked tumorigenesis.

Simonin Y, Vegna S, Akkari L, Grégoire D, Antoine E, Piette J, Floc'h N, Lassus P, Yu GY, Rosenberg AR, Karin M, Durantel D, Hibner U.

PLoS Pathog. 2013 Mar;9(3):e1003234. doi: 10.1371/journal.ppat.1003234. Epub 2013 Mar 21.

14.

Estrogen and retinoic acid antagonistically regulate several microRNA genes to control aerobic glycolysis in breast cancer cells.

Saumet A, Vetter G, Bouttier M, Antoine E, Roubert C, Orsetti B, Theillet C, Lecellier CH.

Mol Biosyst. 2012 Oct 30;8(12):3242-53. doi: 10.1039/c2mb25298h.

PMID:
23064179
15.

H19 antisense RNA can up-regulate Igf2 transcription by activation of a novel promoter in mouse myoblasts.

Tran VG, Court F, Duputié A, Antoine E, Aptel N, Milligan L, Carbonell F, Lelay-Taha MN, Piette J, Weber M, Montarras D, Pinset C, Dandolo L, Forné T, Cathala G.

PLoS One. 2012;7(5):e37923. doi: 10.1371/journal.pone.0037923. Epub 2012 May 25.

16.

Management of anemia in advanced breast and lung cancer patients in daily practice: results of a French survey.

Ray-Coquard I, Morère JF, Scotté F, Cals L, Antoine EC.

Adv Ther. 2012 Feb;29(2):124-33. doi: 10.1007/s12325-011-0093-2.

PMID:
22314432
17.

A case-control study on family dysfunction in patients with alopecia areata, psoriasis and atopic dermatitis.

Poot F, Antoine E, Gravellier M, Hirtt J, Alfani S, Forchetti G, Linder D, Abeni D, Tabolli S, Sampogna F.

Acta Derm Venereol. 2011 Jun;91(4):415-21. doi: 10.2340/00015555-1074.

18.

Experimentally delayed hatching triggers a magnified stress response in a long-lived bird.

Goutte A, Antoine É, Chastel O.

Horm Behav. 2011 Jan;59(1):167-73. doi: 10.1016/j.yhbeh.2010.11.004. Epub 2010 Nov 16.

PMID:
21087608
19.

Efficacy of trastuzumab in routine clinical practice and after progression for metastatic breast cancer patients: the observational Hermine study.

Extra JM, Antoine EC, Vincent-Salomon A, Delozier T, Kerbrat P, Bethune-Volters A, Guastalla JP, Spielmann M, Mauriac L, Misset JL, Serin D, Campone M, Hebert C, Remblier C, Bergougnoux L, Campana F, Namer M.

Oncologist. 2010;15(8):799-809. doi: 10.1634/theoncologist.2009-0029. Epub 2010 Jul 29.

20.

Calpain activation by hepatitis C virus proteins inhibits the extrinsic apoptotic signaling pathway.

Simonin Y, Disson O, Lerat H, Antoine E, Binamé F, Rosenberg AR, Desagher S, Lassus P, Bioulac-Sage P, Hibner U.

Hepatology. 2009 Nov;50(5):1370-9. doi: 10.1002/hep.23169.

PMID:
19711428
21.

Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric study.

Belkacémi Y, Gligorov J, Ozsahin M, Marsiglia H, De Lafontan B, Laharie-Mineur H, Aimard L, Antoine EC, Cutuli B, Namer M, Azria D.

Ann Oncol. 2008 Jun;19(6):1110-6. doi: 10.1093/annonc/mdn029. Epub 2008 Mar 15.

PMID:
18344537
22.

Ectopic pregnancy in a breast cancer patient receiving trastuzumab.

Berveiller P, Mir O, Sauvanet E, Antoine EC, Goldwasser F.

Reprod Toxicol. 2008 Feb;25(2):286-8. doi: 10.1016/j.reprotox.2007.11.004. Epub 2007 Nov 17.

PMID:
18201867
23.

[Management of anaemia in patient with cancer: results of the F-ACT study (French Anaemia Cancer Treatment)].

Guardiola E, Morschhauser F, Zambrowski JJ, Antoine EC.

Bull Cancer. 2007 Oct;94(10):907-14. French.

24.

45- and 70-base DNA supramolecular polymerizations on quartz crystal microbalance biosensor.

Lazerges M, Perrot H, Rabehagasoa N, Antoine E, Compere C.

Chem Commun (Camb). 2005 Dec 28;(48):6020-2. Epub 2005 Nov 7.

PMID:
16333514
25.

Oligonucleotide quartz crystal microbalance sensor for the microalgae Alexandrium minutum (Dinophyceae).

Lazerges M, Perrot H, Antoine E, Defontaine A, Compere C.

Biosens Bioelectron. 2006 Jan 15;21(7):1355-8. Epub 2005 Jul 11.

PMID:
16009543
26.

Serum caspase-1 levels in metastatic melanoma patients: relationship with tumour burden and non-response to biochemotherapy.

Mouawad R, Antoine EC, Gil-Delgado M, Khayat D, Soubrane C.

Melanoma Res. 2002 Aug;12(4):343-8.

PMID:
12170183
27.

Turnover of primary transcripts is a major step in the regulation of mouse H19 gene expression.

Milligan L, Forné T, Antoine E, Weber M, Hémonnot B, Dandolo L, Brunel C, Cathala G.

EMBO Rep. 2002 Aug;3(8):774-9. Epub 2002 Jul 15.

28.

A before-after study using OncoDoc, a guideline-based decision support-system on breast cancer management: impact upon physician prescribing behaviour.

Bouaud J, Séroussi B, Antoine EC, Zelek L, Spielmann M.

Stud Health Technol Inform. 2001;84(Pt 1):420-4.

PMID:
11604774
29.

Phase II study of sequential administration of docetaxel followed by doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer.

Khayat D, Chollet P, Antoine EC, Monfardini S, Ambrosini G, Benhammouda A, Mazen MF, Sorio R, Borg-Olivier O, Riva A, Ramazeilles C, Azli N.

J Clin Oncol. 2001 Jul 15;19(14):3367-75.

PMID:
11454884
30.

Phase I-II study of irinotecan in combination with mitomycin C in patients with advanced gastrointestinal cancer.

Gil-Delgado MA, Antoine EC, Guinet F, Bassot V, Grapin JP, Benhammonda A, Adam R, Castaing D, Bismuth H, Khayat D.

Am J Clin Oncol. 2001 Jun;24(3):251-4.

PMID:
11404495
31.

The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer.

Khayat D, Gil-Delgado M, Antoine EC, Nizri D, Bastian G.

Oncology (Williston Park). 2001 Apr;15(4):415-29; discussion 429-30, 433-4.

32.
33.

Extensive tissue-specific variation of allelic methylation in the Igf2 gene during mouse fetal development: relation to expression and imprinting.

Weber M, Milligan L, Delalbre A, Antoine E, Brunel C, Cathala G, Forné T.

Mech Dev. 2001 Mar;101(1-2):133-41.

34.

Bone-targeted Src SH2 inhibitors block Src cellular activity and osteoclast-mediated resorption.

Violette SM, Guan W, Bartlett C, Smith JA, Bardelay C, Antoine E, Rickles RJ, Mandine E, van Schravendijk MR, Adams SE, Lynch BA, Shakespeare WC, Yang M, Jacobsen VA, Takeuchi CS, Macek KJ, Bohacek RS, Dalgarno DC, Weigele M, Lesuisse D, Sawyer TK, Baron R.

Bone. 2001 Jan;28(1):54-64.

PMID:
11165943
35.

Taxol in the management of cancers of the breast and the ovary.

Khayat D, Antoine EC, Coeffic D.

Cancer Invest. 2000;18(3):242-60. Review. No abstract available.

PMID:
10754992
36.

Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility.

Sanjay A, Houghton A, Neff L, DiDomenico E, Bardelay C, Antoine E, Levy J, Gailit J, Bowtell D, Horne WC, Baron R.

J Cell Biol. 2001 Jan 8;152(1):181-95.

37.

Effect of endogenous interleukin-6 on Fas (APO-1/CD95) receptor expression in advanced melanoma patients.

Mouawad R, Antoine EC, Khayat D, Soubrane C.

Cytokines Cell Mol Ther. 2000 Sep;6(3):135-40.

PMID:
11140882
38.

H19 gene expression is up-regulated exclusively by stabilization of the RNA during muscle cell differentiation.

Milligan L, Antoine E, Bisbal C, Weber M, Brunel C, Forné T, Cathala G.

Oncogene. 2000 Nov 23;19(50):5810-6.

39.

A comparative study of Fas and Fas-ligand expression during melanoma progression.

Soubrane C, Mouawad R, Antoine EC, Verola O, Gil-Delgado M, Khayat D.

Br J Dermatol. 2000 Aug;143(2):307-12.

PMID:
10951137
40.

Management of advanced prostate cancer.

Auclerc G, Antoine EC, Cajfinger F, Brunet-Pommeyrol A, Agazia C, Khayat D.

Oncologist. 2000;5(1):36-44. Review.

41.
43.

[Patient-centered consultation of "good practice guidelines": OncoDoc, a decision support system for the management of breast cancer patients].

Bouaud J, Séroussi B, Antoine EC, Gozy M, Khayat D, Boisvieux JF.

Therapie. 1999 Mar-Apr;54(2):209-15. Review. French.

PMID:
10394256
44.
45.

[Clinical imaging of osteo-condensed metastases].

Buthiau D, Antoine EC, Lapresle P, Wechsler B, Missenard G, Misset JL, Denarnaud J, Khayat D, Ziza JM.

Rev Med Interne. 1999 Apr;20(4):353-64. Review. French.

PMID:
10327481
46.

Hypertextual navigation operationalizing generic clinical practice guidelines for patient-specific therapeutic decisions.

Bouaud J, Séroussi B, Antoine EC, Gozy M, Khayat D, Boisvieux JF.

Proc AMIA Symp. 1998:488-92.

47.

[The role of new drugs in the treatment of locally advanced urothelial tumors of the bladder].

Antoine EC, Khayat D.

Cancer Radiother. 1998 Apr;2 Suppl 1:97s-102s. Review. French.

PMID:
9749088
48.

European experience with irinotecan plus fluorouracil/folinic acid or mitomycin.

Khayat D, Gil-Delgado M, Antoine EC, Coeffic D, Benhammouda A, Grapin JP, Bastian G.

Oncology (Williston Park). 1998 Aug;12(8 Suppl 6):64-7. Review.

49.

Salpêtrière Hospital experience with biochemotherapy in metastatic melanoma.

Antoine EC, Benhammouda A, Bernard A, Youssef A, Mortier N, Gozy M, Nizri D, Auclerc G, Rocher MA, Soubrane CL, Weil M, Khayat D.

Cancer J Sci Am. 1997 Dec;3 Suppl 1:S16-21.

PMID:
9457388
50.

DNA topoisomerase I: customs officer at the border between DNA and RNA worlds?

Tazi J, Rossi F, Labourier E, Gallouzi I, Brunel C, Antoine E.

J Mol Med (Berl). 1997 Nov-Dec;75(11-12):786-800. Review.

PMID:
9428609

Supplemental Content

Loading ...
Support Center